EVO
Evotec SE ADRNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.08B
P/E Ratio
—
EPS
$-0.63
Beta
1.30
52W High
$4.48
52W Low
$2.31
50-Day MA
$2.82
200-Day MA
$3.31
Dividend Yield
—
Profit Margin
-26.00%
Forward P/E
53.48
PEG Ratio
1.42
About Evotec SE ADR
Evotec SE is a leading global biotechnology company based in Hamburg, Germany, that provides comprehensive drug discovery and development solutions to both the pharmaceutical and biotech sectors. The company adopts a collaborative approach, partnering with major pharmaceutical firms and pioneering academic institutions to expedite the development of a diverse portfolio of therapeutic programs, which encompass small molecules, biologics, and cell therapies. With a robust and expanding pipeline, Evotec is well-positioned to capitalize on emerging opportunities within the biopharmaceutical industry, underscoring its crucial role in advancing healthcare innovation and enhancing patient outcomes.
Fundamentals
| Revenue (TTM) | $745.04M |
| Gross Profit (TTM) | $79.42M |
| EBITDA | $-16.69M |
| Operating Margin | -29.60% |
| Return on Equity | -24.10% |
| Return on Assets | -3.14% |
| Revenue/Share (TTM) | $2.10 |
| Book Value | $2.68 |
| Price-to-Book | 1.32 |
| Price-to-Sales (TTM) | 1.44 |
| EV/Revenue | 1.109 |
| EV/EBITDA | 34.36 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -21.70% |
| Shares Outstanding | $355.19M |
| Float | $133.41M |
| % Insiders | 0.00% |
| % Institutions | 2.15% |
Historical Volatility
HV 10-Day
62.87%
HV 20-Day
57.32%
HV 30-Day
62.46%
HV 60-Day
65.11%
HV Rank
69.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($5.19 target)
1
Strong Buy2
Buy1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026